SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001206774-10-002228
Filing Date
2010-10-28
Accepted
2010-10-28 07:33:17
Documents
11
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT regeneron_10q.htm 10-Q 825234
2 AMENDMENT TO THE NON EXCLUSIVE LICENSE AND MATERIAL TRANSFER AGREEMENT exhibit10-1.htm EX-10.1 60548
3 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) exhibit31-1.htm EX-31.1 11563
4 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) exhibit31-2.htm EX-31.2 10031
5 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 exhibit32.htm EX-32 4323
  Complete submission text file 0001206774-10-002228.txt   2909227

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT regn-20100930.xml EX-101.INS 302802
7 XBRL TAXONOMY EXTENSION SCHEMA regn-20100930.xsd EX-101.SCH 15957
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE regn-20100930_cal.xml EX-101.CAL 38642
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20100930_lab.xml EX-101.LAB 172810
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20100930_pre.xml EX-101.PRE 102588
11 XBRL TAXONOMY EXTENSION DEFINITION DOCUMENT regn-20100930_def.xml EX-101.DEF 24663
Mailing Address
Business Address 777 OLD SAW MILL RIVER RD TARRYTOWN NY 10591-6707 9143477000
REGENERON PHARMACEUTICALS INC (Filer) CIK: 0000872589 (see all company filings)

IRS No.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19034 | Film No.: 101146311
SIC: 2834 Pharmaceutical Preparations